Bruce Rosen
Psychiatry · Smithtown, NYNPI 1649343245
Payments from drug & device makers
Across 487 payments — averaging $27.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$3K
- Otsuka America Pharmaceutical, Inc.$1K
- Validus Pharmaceuticals LLC$1K
- AbbVie$962
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$914
- Alkermes, Inc.$875
- plus $6K from 24 others
What the payments were for
- Speaking & faculty fees$1,0698%
- Food & beverage$12,09292%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 83 | $2,644 |
| Otsuka America Pharmaceutical, Inc. | 38 | $1,055 |
| Validus Pharmaceuticals LLC | 15 | $1,052 |
| AbbVie(2 entities) | 50 | $962 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $914 |
| Alkermes, Inc. | 24 | $875 |
| Neurocrine Biosciences, Inc. | 15 | $739 |
| Lundbeck LLC | 34 | $678 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $649 |
| Teva Pharmaceuticals USA, Inc. | 32 | $633 |
| Johnson & Johnson | 17 | $502 |
| Axsome Therapeutics, Inc. | 10 | $383 |
| Merck | 21 | $374 |
| Neuronetics, Inc. | 11 | $238 |
| Alfasigma USA, Inc. | 12 | $218 |
| Vanda Pharmaceuticals Inc. | 7 | $158 |
| Indivior Inc. | 8 | $156 |
| Jazz Pharmaceuticals Inc. | 7 | $140 |
| Idorsia Pharmaceuticals US Inc | 7 | $127 |
| Eisai Inc. | 7 | $114 |
| Bausch Health US, LLC | 6 | $110 |
| Ironshore Pharmaceuticals Inc. | 6 | $102 |
| Shire North American Group Inc | 5 | $95 |
| Avanir Pharmaceuticals, Inc. | 3 | $70 |
| Almatica Pharma LLC | 3 | $70 |
| Kaleo, Inc. | 2 | $31 |
| Livanova USA, Inc. | 1 | $28 |
| Bioxcel Therapeutics, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Orexo US, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,182 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 12 | $6,853 |
| Lisdexamfetamine Dimesylate | 11 | $2,139 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $1,336 |
| Alprazolam | 138 | $1,223 |
| Fluoxetine Hcl | 47 | $1,095 |
| Divalproex Sodium ErDivalproex Sodium | 41 | $1,034 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 56 | $945 |
| Quetiapine Fumarate | 22 | $801 |
| Bupropion XlBupropion Hcl | 38 | $736 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $714 |
| Clonazepam | 69 | $679 |
| Sertraline Hcl | 91 | $488 |
| Escitalopram Oxalate | 40 | $469 |
| Mirtazapine | 36 | $435 |
| Lamotrigine | 29 | $345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $70 | $48891 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Smithtown
- Elyssa BarronWhite Plains$12.8M
- Mark DibuonoStaten Island$11.9M
- Ronald BrennerHempstead$11.5M
- Anton PorsteinssonRochester$7.6M
- Michael LiebowitzNew York$7.1M
- Leslie CitromePomona$5.7M
- John KaneGlen Oaks$4M
- Inna Yuryev-GolgerBrooklyn$3M
- Subhdeep VirkBuffalo$3M
- Paul EderNew York$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.